IvyCap's new India endowment makes first bet on neurotech startup NeuMe
What's the deal? NeuMe Neurotech, a Kozhikode deeptech startup building a brain-computer interface for stroke rehabilitation, has landed the first investment from IvyCapDealroom has a profile for this one. Try Dealroom → Ventures' India Endowment Fund, Sahyadri Startups reported on November 19. The amount was not disclosed. It is also NeuMe's first raise since it was incorporated in September 2025.
What's the endgame? NeuMe pairs a non-invasive BCI headband with adaptive, game-based software for cognitive rehabilitation. The system monitors brain activity in real time and tailors therapy for people recovering from stroke or traumatic brain injury, and for those with neurodegenerative conditions. It plans to serve clinics and home users on a product-as-a-service model.
Why now? The deal was unveiled at Huddle Global 2026, the Kerala Startup Mission's festival in Kovalam from November 12 to 14. IvyCap founder and managing partner Vikram Gupta closed his keynote by handing the stage to NeuMe founder Aparna RVM, e27 reported.
What is the endowment? The India Endowment Fund channels returns from IvyCap's venture business into research, innovation and entrepreneurship, with part of the profits flowing to the alma maters of its investors. Gupta set up India's first such endowment at IIT Delhi in 2019.
What could go wrong? NeuMe says its product is at Technology Readiness Level 5 — tested in a relevant setting, but not yet finished. Turning a BCI rehab system into something clinics will pay for needs clinical evidence, regulatory approval, and a care model that works at home.
The signal: Two things make this small deal worth watching. The money comes from an endowment built from venture profits rather than a standard fund, a model that could give research-heavy startups patient early capital. And NeuMe sits in Kozhikode, outside the metro hubs where most deeptech money goes.
Read more: startupfeed.in
Image credit: Generated with Gemini